Constitutively active mutants of 5-HT4 receptors are they in unique active states?

被引:24
作者
Claeysen, S [1 ]
Sebben, M [1 ]
Bécamel, C [1 ]
Parmentier, ML [1 ]
Dumuis, A [1 ]
Bockaert, J [1 ]
机构
[1] CNRS, UPR 9023, F-34094 Montpellier 5, France
关键词
D O I
10.1093/embo-reports/kve003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Somatic mutations leading to constitutively active G-protein coupled receptors (GPCRs) are responsible for certain human diseases. A consistent structural description of the molecular change underlying the conversion of GPCRs from an inactive R state to an active R* state is lacking. Here, we show that a series of constitutively active 5-HT4 receptors (mutated or truncated in the C-terminal and the third intracellular loop) were characterized by an increase in their denaturation rate at 55 degreesC. The thermal denaturation kinetics were monophasic, suggesting that we were measuring mainly the denaturation rate of R*. Analysis of these kinetics revealed that constitutively active C-terminal domain mutants, were due to a change in the J constant governing the R/R* equilibrium. However, the constitutive activity of the receptor mutated within the third intracellular loop was the result of both a change in the allosteric J constant and a change in the R* conformation.
引用
收藏
页码:61 / 67
页数:7
相关论文
共 28 条
[1]  
Alewijnse AE, 2000, MOL PHARMACOL, V57, P890
[2]   Pharmacological comparison between [H-3]GR 113808 binding sites and functional 5-HT4 receptors in neurons [J].
Ansanay, H ;
Sebben, M ;
Bockaert, J ;
Dumuis, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 298 (02) :165-174
[3]   Molecular tinkering of G protein-coupled receptors: an evolutionary success [J].
Bockaert, J ;
Pin, JP .
EMBO JOURNAL, 1999, 18 (07) :1723-1729
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Pharmacological properties of 5-hydroxytryptamine4 receptor antagonists on constitutively active wild-type and mutated receptors [J].
Claeysen, S ;
Sebben, M ;
Bécamel, C ;
Eglen, RM ;
Clark, RD ;
Bockaert, J ;
Dumuis, A .
MOLECULAR PHARMACOLOGY, 2000, 58 (01) :136-144
[6]  
DUMUIS A, 1988, MOL PHARMACOL, V33, P178
[7]   Activation mechanism of human oxytocin receptor: A combined study of experimental and computer-simulated mutagenesis [J].
Fanelli, F ;
Barbier, P ;
Zanchetta, D ;
De Benedetti, PG ;
Chini, B .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :214-225
[8]   Structural instability of a constitutively active G protein-coupled receptor - Agonist-independent activation due to conformational flexibility [J].
Gether, U ;
Ballesteros, JA ;
Seifert, R ;
SandersBush, E ;
Weinstein, H ;
Kobilka, BK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (05) :2587-2590
[9]   G protein-coupled receptors - II. Mechanism of agonist activation [J].
Gether, U ;
Kobilka, BK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) :17979-17982
[10]  
Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429